Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)

被引：3

作者：

Lotan, Itay ^{[1
]}

Romanow, Gabriela ^{[1
]}

Salky, Rebecca ^{[1
]}

Molazadeh, Negar ^{[1
]}

Vishnevetsky, Anastasia ^{[1
]}

Anderson, Monique ^{[1
]}

Bilodeau, Phillipe-Antoine ^{[1
]}

Cutter, Gary ^{[2
]}

Levy, Michael ^{[1
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroimmunol Clin & Res Lab, Boston, MA 02115 USA

[2] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA

来源：

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 2023年 / 10卷 / 04期

关键词：

OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; CLINICAL SPECTRUM; ADULTS; AUTOIMMUNITY; AQUAPORIN-4;

D O I：

10.1002/acn3.51750

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The mortality rates of individuals with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) are currently unknown. This study aimed to assess the mortality rate in a large cohort of patients with MOGAD. Since none of the patients in our cohort died, we estimated the upper limit of a 95% confidence interval of the crude mortality rate in the cohort to be 2.1%. These data suggest that mortality in MOGAD is lower than that reported in other neuroinflammatory diseases and comparable to the age-adjusted mortality rates of the general population in the United States. Additional studies are warranted to confirm this observation.

引用

页码：664 / 667

页数：4

共 50 条

[1] Myelin Oligodendrocyte Glycoprotein Antibody Disease - MOGAD
Gowda, Vykuntaraju K.
Kumar, Girish
Kinhal, Uddhava V.
Mahadevan, Anita
INDIAN JOURNAL OF PEDIATRICS, 2025, 92 (01): : 89 - 89
[2] HLA Types Associated with Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)
Ahsan, N.
Santoro, J. D.
Saucier, S.
Mitchell, W.
Jafarpour, S.
ANNALS OF NEUROLOGY, 2025, 96 : S119 - S120
[3] A CASE OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE (MOGAD)
Shenouda, Mina A.
Laskova, Violetta
Yang, Yuhong
Riasat, Maria
JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S378 - S378
[4] Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes
Sutton, P. E.
Shah, S.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 146 - 147
[5] Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): a pediatric case report
Gutierrez, Dora S.
Aguirre, Maria E. Balbuena
Castellano, Silvia D.
ARCHIVOS ARGENTINOS DE PEDIATRIA, 2024,
[6] Course of myelin oligodendrocyte glycoprotein-associated disease (MOGAD) - a cohort of patients
Hanakova, P.
Danhofer, P.
Dufek, M.
Senkyrik, J.
Kominek, M.
Dominik, P.
Oslejskova, H.
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2024, 87 (02) : 122 - 131
[7] Paraneoplastic myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a retrospective cohort study and literature review
Trentinaglia, Milena
Dinoto, Alessandro
Carta, Sara
Chiodega, Vanessa
Ferrari, Sergio
Andreone, Vincenzo
Maniscalco, Giorgia Teresa
Mariotto, Sara
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 676 - 677
[8] Focal seizures as a confusing onset of recurrent MOGAD (myelin oligodendrocyte glycoprotein antibody disease)
Jaczak-Gozdziak, M.
Steinborn, B.
EPILEPSIA, 2023, 64 : 447 - 448
[9] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
Abdullah Al-Ani
John J. Chen
Fiona Costello
Journal of Neurology, 2023, 270 : 4132 - 4150
[10] Challenges in the Diagnosis and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Pandit, Lekha
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2025, 28 (01) : 10 - 16

← 1 2 3 4 5 →